FORT LAUDERDALE, Fla., March 19, 2013 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO) today announced that it has filed complaints against Stanmore Implants Worldwide, Ltd. of Elstree, United Kingdom and Stanmore Inc. of Plymouth, Massachusetts with the U.S. International Trade Commission, and the U.S. District Courts of the Northern District of California and the District of Massachusetts collectively alleging infringement of three patents by Stanmore. The patents at issue relate to computerized orthopedic surgical devices and software, and the patent infringement actions are directed at Stanmore’s computerized orthopedic surgery guidance systems, including Stanmore’s Sculptor Robotic Guidance Arm.
“MAKO has invested tens of millions of dollars developing a significant portfolio of technologies,” said Maurice R. Ferré, M.D., president and chief executive officer of MAKO. “We are intent on protecting our leadership position in the field of robotically assisted orthopedic surgery.”
About MAKO Surgical Corp.
MAKO Surgical Corp. is a medical device company that markets its RIO Robotic-Arm Interactive Orthopedic system, with specific applications for partial knee resurfacing and total hip replacement, and proprietary RESTORIS Family of Implants for orthopedic procedures called MAKOplasty. The RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology, which enables accurate, consistently reproducible bone resection for accurate insertion and alignment of RESTORIS knee and hip implants. The MAKOplasty solution incorporates technologies enabled by an intellectual property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent applications. Additional information can be found at www.makosurgical.com.